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IL-6 controls susceptibility to helminth infection by
impeding Th2 responsiveness and altering the Treg
phenotype in vivo
Katherine A. Smith and Rick M. Maizels
Institute of Immunology and Infection Research, University of Edinburgh, United Kingdom
IL-6 plays a pivotal role in favoring T-cell commitment toward a Th17 cell rather than
Treg-cell phenotype, as established through in vitro model systems. We predicted that
in the absence of IL-6, mice infected with the gastrointestinal helminth Heligmosomoides
polygyrus would show reduced Th17-cell responses, but also enhanced Treg-cell activ-
ity and consequently greater susceptibility. Surprisingly, worm expulsion was markedly
potentiated in IL-6-deficient mice, with significantly stronger adaptive Th2 responses in
both IL-6−/− mice and BALB/c recipients of neutralizing anti-IL-6monoclonal Ab. Although
IL-6-deficient mice showed lower steady-state Th17-cell levels, IL-6-independent Th17-
cell responses occurred during in vivo infection. We excluded the Th17 response as a
factor in protection, as Ab neutralization did not modify immunity to H. polygyrus infec-
tion in BALB/c mice. Resistance did correlate with significant changes to the associated
Treg-cell phenotype however, as IL-6-deficient mice displayed reduced expression of
Foxp3, Helios, and GATA-3, and enhanced production of cytokines within the Treg-cell
population. Administration of an anti-IL-2:IL-2 complex boosted Treg-cell proportions in
vivo, reduced adaptive Th2 responses to WT levels, and fully restored susceptibility to
H. polygyrus in IL-6-deficient mice. Thus, in vivo, IL-6 limits the Th2 response, modifies
the Treg-cell phenotype, and promotes host susceptibility following helminth infection.
Keywords: IL-6  Parasite infection  Th2 response  Treg cells
 Additional supporting information may be found in the online version of this article at thepublisher’s web-site
Introduction
Interleukin-6 (IL-6) is a pleiotropic cytokine produced by multiple
cell types and with wide-ranging functions and actions. As well as
playing a role in the activation and differentiation of macrophages,
lymphocytes, and the terminal differentiation of B cells, IL-6 also
actively regulates acute and chronic inflammation [1].
Studies in gene-targeted mice have revealed that IL-6 is impor-
tant in restraining the acute local and systemic inflammatory
Correspondence: Dr. Rick M. Maizels
e-mail: r.maizels@ed.ac.uk
response following exposure to endotoxin [2] while reducing sus-
ceptibility to bacterial, viral, and fungal infection [3,4]. IL-6 also
has a crucial role in promoting the pathogenesis of chronic con-
ditions such as murine inflammatory bowel disease [5], collagen-
induced arthritis [6], and in the development of tumors [7].
IL-6 and IL-6-related cytokine responses are transmitted
through gp130, activate the JAK-STAT1/3 pathway, and initi-
ate gene transcription in a range of target cells (reviewed in
[8]). Na¨ıve T cells activated in the presence of IL-6 and TGF-β
differentiate to Th17 cells to drive experimental autoimmune
encephalomyelitis (EAE) and collagen-induced arthritis, both
of which are alleviated in IL-6−/− mice (reviewed in [9]).
Ab-mediated IL-6 blockade has also been shown to inhibit EAE
C© 2013 The Authors. European Journal of Immunology published by Wiley-VCH Verlag GmbH & Co.
KGaA, Weinheim.
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development by limiting the induction of Ag-specific Th17 cells
[10].
In the absence of IL-6, na¨ıve T cells activated with IL-2 and
TGF-β become Foxp3+ peripherally derived Treg (pTreg) cells
[11]. The production of IL-6 from activated DCs has been shown
to inhibit Treg-cell function [12], and expansion [13] or even
induce thymus-derived Treg (tTreg) cells to become Th17 cells
in the presence of TGF-β [14]. In some settings, IL-6 can also
promote Th2-cell differentiation [15] although its absence does
not affect the development of Th2 responses to schistosome eggs
[16,17].
In this study, we examined the contribution of IL-6 to the
inflammatory and immunoregulatory response generated follow-
ing infection with the Th2-cell and Treg-cell-inducing gastroin-
testinal helminth Heligmosomoides polygyrus [18,19]. Our results
revealed that IL-6 determines susceptibility to helminth infection
by modifying the phenotype of the Treg-cell population and lim-
iting protective Th2 responsiveness. Early stimulation of Treg-
cell populations in the absence of IL-6 was crucial in regulating
excessive pro-inflammatory responses and preventing resistance
to helminth infection.
Results
IL-6 deficiency confers enhanced resistance to chronic
helminth infection
In order to assess the contribution of IL-6 to chronic helminth
immunity in a finely balanced Th2/Treg setting, we first deter-
mined the survival of adult worms and the production of eggs as
a measure of fitness over a 28-day period in IL-6-deficient and
IL-6-sufficient BALB/c mice infected with H. polygyrus. After the
first 14 days of infection, following emergence of the adult worm
into the lumen, we found a significant reduction in egg burdens,
a significant increase in intestinal granulomas as well as elevated
Th2 responses in infected IL-6−/− mice (Fig. 1A and B and data
not shown), although adult worm burdens did not differ at this
time point (Fig. 1C). At day 28 following infection, when gradual
expulsion of the adult worm has begun in BALB/c mice, striking
reductions in both egg and adult worm numbers were observed in
IL-6−/− hosts, compared with those of their BALB/c counterparts
(Fig. 1D and E) and although granuloma numbers had decreased
in frequency in both strains, there remained significantly more in
the IL-6−/− host, correlating with elevated Th2 responses in these
mice (data not shown).
IL-6-deficient mice display a more potent adaptive
Th2 response following helminth infection
Given the role of IL-4 and IL-13 in mediating helminth expul-
sion [20] and the contribution of innate lymphoid and adaptive
T-cell populations to the production of these cytokines following
helminth infection [21], we hypothesized that the late phase of
worm expulsion would be determined by the balance of regulatory
and effector (Treg:Teff) T-cell responses established in the initial
priming phases of infection. The increased number of intestinal
granulomas in IL-6−/− mice also indicated potentiation of type
2 responses early in infection, as these are foci of alternatively
activated macrophages, which form in an IL-4Rα-dependent man-
ner [22]. To characterize the Treg:Teff dynamic, we performed a
number of measures of the innate and adaptive type-2 response.
On day 7 followingH. polygyrus infection, CD4+ mesenteric lymph
node cells (MLNCs) from IL-6−/− mice expressed higher levels of
the Th2 cytokines IL-4, IL-13, and the regulatory cytokine IL-10 by
intracellular staining (Fig. 2A) and higher levels of IL-4 and IL-10
following Ag-specific restimulation (Fig. 2B). In WT mice, >50%
of IL-10+ T cells were also producing IL-4 (Fig. 2C), reflecting
the integral part IL-10 plays in both the induction and expression
of the Th2 response to helminths [23]. In IL-6−/− mice, an even
greater proportion of IL-10 is co-expressed with IL-4, indicating
again an intensification of Th2 responsiveness in the absence of
IL-6.
To establish that the phenotype of the IL-6−/− mice was directly
attributable to the actions of IL-6 and not due to other hemato-
logical changes known to occur in the IL-6−/− strain [24], we also
depleted WT BALB/c mice with the anti-IL-6 monoclonal Ab 20F3
and found that Ag-specific Th2 responses to infection (as mea-
sured by IL-4 and IL-10) were elevated in treated mice MLNCs
(Fig. 2D).
IL-6 has been shown to play an important role in driving ter-
minal B-cell differentiation [1], and we therefore assessed the
longer term development of Ag-specific Ab production in the sera
of BALB/c and IL-6-deficientmice. By day 21 IL-6−/−-infectedmice
developed much higher Ag-specific IgE levels (Fig. 2E), whereas
levels of H. polygyrus excretory-secretory antigens (HES)-specific
IgM, IgG1, and IgG2a were unaffected (data not shown).
To next evaluate the impact of IL-6 deficiency on the innate
immune response to H. polygyrus infection, we then assessed the
generation of eosinophilia, which in other helminth infections
can occur independently of the adaptive Th2 compartment in
nu/nu [25], STAT-6−/− [26], and RAG-deficient [27] animals.
At day 7 and 14, IL-6-deficient mice exhibited higher levels of
MLNC eosinophilia than BALB/c mice, consistent with reports that
IL-6−/− mice display enhanced lung eosinophilia during Schisto-
soma mansoni infection [28] (Fig. 2F and Supporting Information
Fig. 1G). However, the absence of IL-6 did not alter the early
day 5 induction of CD3−CD19−IL-13+ type 2 innate lymphoid cell
(ILC-2) populations postinfection in theMLNCs, indicating specific
effects on Th2 polarization in the absence of IL-6 (Fig. 2G).
IL-6-independent generation of Th17 responses in
vivo following helminth infection
IL-6 is well known as a promoter of Th17 differentiation in settings
such as autoimmunity in mice [10]. In the absence of IL-6, the bal-
ance between Th17 and Th2 development may be altered, and we
therefore compared Th17-cell frequencies in MLNC from BALB/c
C© 2013 The Authors. European Journal of Immunology published by
Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.
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Figure 1. Phenotype of IL-6-deficient BALB/c mice infected with H. polygyrus. (A) Egg burdens in BALB/c and IL-6−/− mice 15 days postinfection
with H. polygyrus (Hp) are shown. (B) Day 14 intestinal granulomas are shown. (C) Day 14 worm burden is shown. (D) Day 28 egg burdens are shown.
(E) Day 28 worm burden in H. polygyrus-infected BALB/c and IL-6−/− mice are shown. Symbols represent individual mice and data are from one
experiment representative of four experiments performed; *p < 0.05, **p < 0.01, unpaired t test.
and IL-6-deficientmice at steady state and days 5, 7, 14, and 28 fol-
lowing H. polygyrus infection. Na¨ıve IL-6−/− mice had fewer Th17
(CD4+IL-17+) cells than BALB/c mice, as observed in mice lack-
ing IL-6 gp130 signaling [29] whereas levels of CD4+IFN-γ+ cells
were similar between genotypes (Fig. 3A). Despite this deficiency,
following day 5 H. polygyrus infection of IL-6−/− mice, there was
a significant outgrowth of Th17 cells to levels similar to those in
infected BALB/c mice (Fig. 3A), reflecting a greater fold increase
of Th17 cells in IL-6-deficient than in sufficient mice following
helminth infection (Fig. 3B). A similar IL-6-independent expansion
of MLNC Th17 cells occurred following infection with another gas-
trointestinal nematode parasite, Nippostrongylus brasiliensis (Sup-
porting Information Fig. 1A). Hence, following helminth infection,
similar levels of Th17 cells are seen in susceptible and resistant
genotype hosts.
To identify other potential stimulators of Th17 in the IL-6-
deficient setting, we also examined IL-21 [30], IL-23 [31], and
IL-1β [32] expression within whole MLNC, each implicated in
the development and stabilization of CD4+IL-17+ T cells in vitro
and in mucosal tissues. However, at day 7 following H. poly-
gyrus infection, we found neither compensatory upregulation of
IL-21 or IL-1β in IL-6-deficient mice, nor did we find dysregulated
expression of the IL-23R, responsive to IL-23, by quantitative PCR
(Supporting Information Fig. 1B).
The IL-6-independent generation of Th17-cell responses to
helminth infections (Fig. 3B) raised the question of the func-
tional contribution of these cells to helminth immunity. We there-
fore administered anti-IL-17 neutralizing Ab to BALB/c mice and
assessed whether this was able to modify egg and worm burdens
in vivo. We found that Ab treatment over 14 days did not alter egg
or worm burden in BALB/c mice (Fig. 3C), or the Th2 and granulo-
matous response in vivo (data not shown). Hence, the heightened
resistance of IL-6−/– mice cannot be attributed to a pivotal role for
IL-17 during infection.
Altered Foxp3+ Treg-cell phenotype in H. polygyrus-
infected IL-6-deficient and IL-6-depleted mice
A further subset of T cells, which is prominent during H. poly-
gyrus infection is the Foxp3+ Treg-cell population [18], whose
suppressive function may play an important role in determining
the outcome of infection [19]. As depletion of Treg cells during
acute H. polygyrus infection of Foxp3-diphtheria toxin receptor-
expressing DEREG mice resulted in an amplified antiparasite Th2
response [33], we considered the possibility that aberrant Treg-
cell development permitted a stronger and protective Th2 arm
to evolve in IL-6-deficient mice. Altered Treg-cell expression could
also arise inmice lacking IL-6 given the dominant role this cytokine
is reported to play in inhibiting Foxp3+ T-cell induction following
immunization in vivo or in the presence of TGF-β in vitro [9].
When the MLNC CD4+ T-cell compartment was analyzed for
expression of the Treg-cell marker Foxp3, similar proportions were
found in na¨ıve BALB/c and IL-6-deficient mice, as also noted in
mice impaired in gp130 signaling [29] (Fig. 4A); in both geno-
types, H. polygyrus infection stimulates a small but significant
increment in the percentage of Foxp3+ T cells.
The expression of Foxp3 is strongly associated with Treg-cell
activity and repression of effector CD4+ T-cell lineage differ-
entiation [34]. Notably, the expression intensity of Foxp3 was
C© 2013 The Authors. European Journal of Immunology published by
Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.
www.eji-journal.eu
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Figure 2. Adaptive Th2 responses toH. polygyrus in IL-6-deficientmice, or BALB/cmice treatedwith anti-IL-6 Ab. (A) IL-4, IL-10, and IL-13 expression
by CD4+ BALB/c and IL-6−/− MLNCs 7 days postinfection was determined by intracellular staining. (B) IL-4 and IL-10 release from media- or HES-
stimulated day 7 BALB/c and IL-6−/− MLNCs was determined by ELISA. (C) Co-expression of IL-4 and IL-10 by day 7 BALB/c and IL-6−/− MLNCs was
determined by flow cytometry. (D) IL-4 and IL-10 release from media- or HES-stimulated H. polygyrus-infected BALB/c MLNCs treated with 200 μg
of a neutralizing anti-IL-6 Ab or a rat IgG control on days 0, 2, 4, and 6 postinfection was determined by ELISA. (E) Day 21 serum Ag-specific IgE to
HES in naı¨ve (diamond symbol) and infected (circle symbol) BALB/c (dark gray) and IL-6−/− (light gray) mice is shown. (F) Day 14 MLNC eosinophilia
in BALB/c and IL-6−/− mice is shown. (G) Day 5 intracellular staining of MLNC nuocyte populations (CD3−CD19−IL-13+ cells) in BALB/c and IL-6−/−
mice are shown. Symbols represent individual mice and data are from one experiment representative of two experiments performed; *p < 0.05,
**p < 0.01, ***p < 0.001, one-way ANOVA.
significantly lower in na¨ıve IL-6−/− compared with that in BALB/c
mice, while the disparity between the strains narrowed following
infection (Fig. 4B and C).
The plasticity of Foxp3+ cells is being increasingly recognized,
and the deletion of Foxp3 expression can result in loss of sup-
pressive function and acquisition of pro-inflammatory cytokine
production, particularly IL-2 and IFN-γ [35] while in vitro, IL-6
can reprogram fully differentiated Treg cells toward the Th17
lineage [14, 36]. In order to assess the impact of IL-6 defi-
ciency on Treg-cell function in vivo following helminth infec-
tion, we performed Foxp3 staining in concert with intracellular
cytokine staining at a time-point when effector cell responses
were dysregulated in IL-6−/− mice (day 7). While IL-2 and
IL-17 expression by MLNC Foxp3+ Treg cells was very low in
both genotypes of naive mice, infection induced a significant
increase in Foxp3+IL-17+ cell numbers in the BALB/c strain.
Infected IL-6−/− mice, moreover, showed raised IL-2 expres-
sion among the Foxp3+ population, which also displayed sig-
nificantly higher IL-17 production compared to BALB/c mice
(Fig. 4D and E).
C© 2013 The Authors. European Journal of Immunology published by
Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.
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Figure 3. Th17 levels in IL-6-deficient mice following H. polygyrus infection. (A) Intracellular staining of MLNCs from naı¨ve and 5-day H. polygyrus-
infected BALB/c and IL-6−/− CD4+ T cells for IL-17A and IFN-γ. (B) The fold increase in Th17 cells by intracellular staining of MLNCs from infected
BALB/c and IL-6−/− mice compared with average naı¨ve levels at the respective time-points is shown. (C) Egg and worm burdens at day 14 of
H. polygyrus infection in BALB/c mice treated with 50 μg of neutralizing anti-IL-17 Ab, or rat IgG2a control, at days 0, 3, 6, and 9 postinfection, are
shown. Data shown are (A, B) pooled from two independent experiments each with n ≥ 3 mice/group or (C) from one experiment representative
of two performed; *p < 0.05, **p < 0.01, ***p < 0.001, one-way ANOVA (A), unpaired t test (B, C).
We next tested expression of the transcription factor GATA-3
at steady state and in infected mice, which has recently been rec-
ognized to control both Foxp3 expression in vivo [37] and Foxp3+
T-cell fate and function [38]. In the absence of IL-6, significantly
fewer MLNC Treg cells expressed GATA-3 (Fig. 4F and G), and in
particular expression levels (as measured by intensity of GATA-3
staining within Foxp3+ T cells) were significantly diminished both
in steady state and in response to infection at a time-point pre-
ceding effector cell dysregulation (day 5; Fig. 4H). Although the
proportion of GATA-3+ Treg cells increases with infection in both
strains, the proportion of GATA-3+ Treg cells and expression of
GATA-3 within the MLNC Treg-cell population remains signifi-
cantly lower in IL-6−/− mice.
Another transcription factor, Helios, has been closely associ-
ated with Treg cells, having first been used to distinguish thymic
Treg cells from Foxp3+Helios− peripherally derived Treg cells
(pTreg cells) [39]. However, Helios may also be expressed dur-
ing activation of Foxp3− T cells [40] while very recent studies
point to a role in stabilizing Foxp3 expression in human Treg
cells [41]. Hence, Helios− cells have greater potential to replace
Foxp3 expression with that of effector cytokines such as IL-2,
IL-17, and IFN-γ [39]. Moreover, transgenic overexpression of IL-6
in vivo significantly reduces the frequency of Foxp3+Helios− cells,
suggesting a link with Helios expression [42]. In accordance with
these data, we found significantly lower levels of Helios expression
within the MLNC Foxp3+ Treg-cell population of IL-6-deficient
mice, both in terms of proportion (Fig. 4I) and staining intensity
(Fig. 4J and K), which were not recovered 5 days after H. poly-
gyrus infection. Interestingly, we also found that Helios expression
by MLNC Foxp3+ cells correlated with GATA-3, CD45RB, OX-40,
and Foxp3 expression as well as Ki67 (a marker of proliferation)
but not CD44, CD25, or ICOS. Hence, Helios may more reliably
mark Foxp3+ Treg-cell stability and function in vivo (Supporting
Information Fig. 1C and D) rather than activation status per se.
In order to address whether induced Treg cells were aberrent
in IL-6−/− mice following H. polygyrus infection, independently
of Helios expression, we assessed the ability to induce Foxp3
expression in purified CD4+ T cells cultured in the presence of
C© 2013 The Authors. European Journal of Immunology published by
Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.
www.eji-journal.eu
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MLNCs of naı¨ve or 5-day infected BALB/c and IL-6−/− mice is shown. (G) Representative flow cytometry plot of MLNC CD4+ Foxp3 and GATA-3
expression in naı¨ve and 5-day H. polygyrus-infected BALB/c and IL-6−/− mice is shown. (H) MFI of GATA-3 expression in the same cell populations
as (G). (I) The frequency of Helios+ cells within the same cell populations as (G) is shown. (J) Representative histogram of Helios expression within
CD4+Foxp3+ MLNCs, colored as in (B) is shown. (K) MFI of Helios expression is shown. (A–K) Data shown are from one experiment representative
of three performed with ≥4 mice per group. (L) Proportion of Foxp3+ cells among naı¨ve BALB/c and IL-6−/− CD4+ cells stimulated in vitro with
1 μg plate-bound anti-CD3/CD28 and 20 ng/mL rIL-2 for 72 h at 37◦C/5% CO2 is shown. One experiment representing three in vitro repeats with
duplicate or triplicate wells for each condition is shown. (M) Proportion of CD4+KJ126+Foxp3GFP+ MLNCs derived in vivo following CD4+Foxp3GFP−
FoxDO11.10 transfer and administration of 1% OVA protein in the water at day 7 postinfection or in naı¨ve mice is shown. Each symbol represents
an individual mouse and data were pooled from two in vivo experiments; *p < 0.05, **p < 0.01, ***p < 0.001, one-way ANOVA.
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anti-CD3/CD28, IL-2, and TGF-β; we also tested HES, which we
previously demonstrated can mimic TGF-β as a Treg-cell-driving
agent [19]. As shown in Fig. 4L, cells from both strains were able
to respond similarly and increase the proportion of CD4+Foxp3+
T cells under Treg-cell-inducing conditions. To confirm that Treg-
cell induction was similar within an in vivo setting, we also
tested de novo Ag-specific Treg-cell induction in vivo by transfer-
ring FACS-sorted Fox.DO11.10 CD4+GFP− cells into BALB/c and
IL-6−/− mice in the absence and presence of H. polygyrus infec-
tion and administered soluble OVA protein orally [19]. Following
infection, an increase in the proportion of MLNC Foxp3+CD4+
cells within the transferred Fox.DO11.10 population occurred in
both strains to a similar extent (Fig. 4M). These results indicate
that loss of Treg-cell function may specifically occur within the
tTreg-cell population in mice deficient in IL-6.
Rescue of Foxp3+ Treg-cell phenotype and reversion
to susceptibility by IL-2:anti-IL-2 treatment
To test the hypothesis that mice lacking IL-6 have an impaired
CD4+Foxp3+ Treg-cell compartment, we tested the effect of
selectively boosting this population through administration of an
IL-2:anti-IL-2 complex, which has been found by other investiga-
tors to expand CD4+Foxp3+ Treg cells in vivo [43–45], stabilize
Treg-cell Foxp3 expression [46,47], and increase GATA-3 expres-
sion [38]. One intraperitoneal injection of the complex immedi-
ately following infection with H. polygyrus resulted in a dramatic
increase in the percentage of Foxp3+ Treg cells and increased
expression of Helios on Foxp3+ T cells in the MLNCs of IL-6-
deficient mice by day 7 postinfection (Fig. 5A).
In accordance with reports that the IL-2:anti-IL-2 complex sta-
bilizes Foxp3 expression [47], and that CD25+ Treg cells are less
prone to switch into effector mode [48] we find that administra-
tion of the complex significantly reduces MLNC cytokine produc-
tion by Foxp3+ T cells in terms of IL-10, with a downward trend for
IL-2 production, without affecting IL-17 (Supporting Information
Fig. 1E).
Treg-cell expansion and stabilization was associated with sup-
pression of higher Th2 responses in the IL-6-deficient mice, as
measured both by intracellular cytokine staining of CD4+ MLNCs
for IL-4, IL-10, and IL-13, as well as Ag-specific restimulation of
whole MLNCs (Fig. 5B and Supporting Information Fig. 1F). These
changes were reflected in an associated reduction in the granulo-
matous response in IL-6−/− mice treated with the IL-2C (Fig. 5C)
and are consistent with observations in a mouse model of air-
way allergic inflammation [44]. Interestingly, while IL-2:anti-IL-
2 complex in the airway model was reported to suppress lung
eosinophilia, helminth-induced eosinophilia in the MLNCs was
unaffected by administration of the complex (Supporting Infor-
mation Fig. 1G).
Most importantly, administration of IL-2:anti-IL-2 complex
also evoked a dramatic switch in infection status. From 14 days
postinfection, treated mice showed greatly increased egg burdens
through to 28 days postinfection (Fig. 5D) at which time sub-
stantially higher worm burdens had persisted (Fig. 5E). Hence
the remarkable phenotype of helminth-infected IL-6-deficientmice
can be fully reversed by intervention to reinvigorate the Foxp3+
Treg-cell compartment.
Discussion
IL-6 plays many crucial roles in the immune system, not least
in the differentiation and maturation of different T-cell subsets
[11,49,50]. Our data show that in the absence of IL-6, more potent
Ag-specific Th2 responses can develop resulting in increased
immunity and parasite resistance. Immunity was not due to lower
proportions of Th17 cells in the MLN in mice lacking IL-6, as
these mice were able to generate significantly increased propor-
tions of Th17 cells equivalent to the level of WT mice following
infection. Furthermore, administration of a neutralizing anti-IL-
17 Ab had no impact on egg burden or worm burden in WT
mice. IL-6-deficient mice also had an altered Treg phenotype,
expressing lower levels of Foxp3, Helios, and GATA-3 at steady
state and producing higher levels of IL-2 and IL-17 following
H. polygyrus infection. The resistant phenotype of the IL-6-
deficient mouse could be fully reversed by administration of an
anti-IL-2:IL-2 complex, rescuing the Treg-cell phenotype, inhibit-
ing Ag-specific Th2 responses, and restoring susceptibility to
chronic helminth infection.
Previous work had established that mice deficient in IL-6 are
not impaired in their ability to produce an in vivo Th2 response fol-
lowing injection of S. mansoni eggs [17]. Moreover, Th2 responses
are enhanced following mycobacterial vaccination of mice defi-
cient in, or neutralized for, IL-6 [51]. We now demonstrate that
enhanced Ag-specific Th2 responses of IL-6-deficient mice can be
reproduced in WT mice by administration of neutralizing anti-IL-6
following H. polygyrus infection. Interestingly, CD4+ T cells within
the MLNC are the predominant source of the IL-10 in response to
H. polygyrus infection, similar to the situation seen in human filari-
asis infections [52]; however, it remains to be seen whether those
CD4+IL-10+IL-4+ co-expressing cells elicited following H. poly-
gyrus infection contribute to a similar state of Ag-specific hypore-
sponsiveness as that apparent in human disease.
Primary and secondary infection with H. polygyrus promotes
a T-cell-dependent IgE response, which requires IL-4 signaling in
vivo [53]. A seminal study demonstrated that IgE deficiency had
no impact on protective immunity following secondary challenge
with H. polygyrus, and that only passive transfer of polyclonal
IgG Ab was able to significantly reduce adult worm burden fol-
lowing primary infection [54]. Here, we show that Ag-specific
IgE is increased following H. polygyrus infection of IL-6-deficient
mice, commensurate with increased Th2 responses in the same
mice, however given the aforementioned findings, it is unlikely
that increased IgE contributes to the improved resistance of these
mice following primary infection with H. polygyrus. Mice deficient
in IL-6 also exhibited increased eosinophilia in the MLN, consis-
tent with reports that IL-6-deficient mice display enhanced lung
eosinophilia and parasite mortality following S. mansoni infection
C© 2013 The Authors. European Journal of Immunology published by
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Figure 5. Treg-cell phenotype and helminth survival in IL-6-deficient mice treated with anti-IL-2:IL-2 complex (A) Percentages of Foxp3+ within
CD4+ MLNCs (left) and Helios+ T cells within Foxp3+ (right) in naı¨ve and at day 7 postinfection H. polygyrus-infected BALB/c and IL-6−/− mice
given 25 μg isotype control (ISO) or a complex of rmIL-2 (2.5μg):α-IL-2m Ab (25 μg; IL-2C) immediately after infection are shown. (B) The frequency
of IL-4 and IL-10 expression following intracellular staining of CD4+ MLNCs (top) or IL-4 and IL-10 release from media or HES-stimulated whole
MLNC cultures (bottom) at day 7 postinfection in naı¨ve and H. polygyrus-infected BALB/c and IL-6−/− mice treated with an isotype control (ISO) or
IL-2:anti-IL-2 complex (IL-2C) immediately after infection are shown. Symbols represent individual mice and data shown are from one experiment
representative of two replicate experiments performed. (C) The number of day 28 intestinal granulomas in H. polygyrus-infected BALB/c and IL-6−/−
treated with ISO or IL-2C are shown. (D) Egg burdens over time in IL-6−/− mice treated with ISO or IL-2C are shown. (E) Adult worm burdens at day
28 postinfection in IL-6−/− mice treated with ISO or IL-2C are shown. (C–E) Symbols represent individual mice and data shown were pooled from
three experiments with n > 5 mice/group; *p < 0.05, **p < 0.01, ***p < 0.001, one-way ANOVA (A–C), unpaired t test (D, E).
[28]. In this model, IL-6 was expressed in the pulmonarymicrovas-
culature of infected mice, highlighting the importance of cytokine
production by the endothelium in mediating parasite clearance.
IL-6 exerts an important influence on Th17-cell differentia-
tion and mediates the dichotomy underlying the generation of
pathogenic Th17 and Treg cells induced by TGF-β [11]. As in
the case of mice lacking IL-6 gp130 signaling [29], we found
that mice lacking IL-6 had lower proportions of Th17 cells in the
MLN at steady state. However, following infection with two dif-
ferent parasitic helminths, these mice were able to generate sig-
nificantly increased percentages of Th17 cells equivalent to the
level of infected WT mice. The generation of Th17 cells in an
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IL-6-independent manner has been described through an IL-21-
linked pathway [30] and through microbiota-induced IL-1β in the
intestine [32]. Although we found no compensatory upregulation
of either of these factors in IL-6-deficient mice by quantitative
PCR, it is likely that infection stimulates other factors that may,
for example, activate STAT3 through the relatively promiscuous
IL-6/IL-12 family of ligands. This may even extend to mediators
such as IL-9 [55], which is not only upregulated in helminth infec-
tion, but more intensely so in IL-6-deficient mice. These possibili-
ties are currently under investigation in our laboratory.
IL-6 is known to strongly influence the size and nature of the
Treg-cell compartment in mice, but in a manner highly dependent
upon the context of the inflammatory condition. In graft-versus-
host disease, the blockade of IL-6R-mediated signaling increases
Treg-cell numbers at the expense of Th1/17, dampening immune
reactivity [56]. A similar switch is accompanied by the rapid gen-
eration of a strong Th2 response and enhanced immunity to the
intestinal nematode Trichuris muris, in highly susceptible IL-10-
deficient mice in which T cells cannot respond to IL-6 [57]. More
recent studies have implicated differential cytokine signal require-
ments for the generation of pTreg cells and tTreg cells [58] and
have suggested that IL-6 may play a role in controlling pTreg-cell
generation in vivo at steady state [38,42].
Although Helios has been used as a marker of natural Treg
cells, new studies have suggested that its expression more closely
reflects the activation status of Treg cells [40]. In this light, we
measured CD25, CD44, and ICOS as markers of activation, which
might correlate with Helios expression, but found this not to be
the case either at steady state or following infection (Supporting
Information Fig. 1C and D). Interestingly, Ki67 staining of the
Foxp3+ Treg-cell population did significantly positively correlate
with Helios expression, implying that Helios+ cells have a higher
constitutive turnover rate in steady state, and are the major reg-
ulatory population responding to infection. As IL-6−/− Treg cells
expressed lower levels of Helios, our results imply that their pro-
liferation may be impaired, perhaps explaining the more vigorous
Th2 responses in these mice.
Expression of Helios also strongly positively correlates with that
of CD45RB, GATA-3, and OX40 as well as of Foxp3 itself. Given the
critical role Foxp3 plays in the suppressive function of Treg cells
in vitro and in vivo [34,59], these results indicate that IL-6 may be
required to stabilize Treg-cell function in vivo. This conclusion is
supported by lower GATA-3 expression in IL-6-deficient mice, and
recent studies highlighting that this transcription factor controls
Foxp3 expression and thereby Treg-cell function [37, 38]. OX40
also plays an important role in maintaining Treg-cell fitness [60]
and it may be that selective loss of OX40 expression on the Treg-
cell population in IL-6-deficient mice may render these cells less
able to proliferate in response to ligation [61]. Although CD45RB
expression also correlated with Helios within the Treg-cell popula-
tion, as noted previously [40], lower CD45RB expression was also
apparent within the Foxp3− population of mice deficient in IL-6,
suggesting a global impact on the CD4+-cell population, rather
than a specific effect on Treg-cell phenotype.
The possibility that a deficiency in IL-6 may destabilize tTreg-
cell function in vivo was further tested by de novo induction of
Treg cells in vivo and in vitro; as these processes occurred normally
in mice deficient in IL-6, destabilization of Treg-cell function must
occur within the tTreg-cell population, as postulated elsewhere
[42]. The use of an anti-IL-2:IL-2 complex, which can stabilize
Foxp3 and GATA-3 expression in vivo [38, 42], was able to fully
reverse the phenotype of IL-6-deficient mice providing further evi-
dence that defective tTreg-cell function enhances immunity and
worm expulsion in these mice. Finally, identifying the major con-
tributor of IL-6 from a diverse range of cell types to this striking
phenotype remains a key area of interest for further research in
this infection setting.
Materials and methods
Mice
BALB/c mice were bred in-house at the University of Edinburgh;
IL-6-deficient strains originated from Kopf et al. [3] and were
backcrossed to BALB/c by Paul Garside (University of Strathclyde)
before being rederived in-house.
Ethics statement
All animal protocols adhered to the guidelines of the UK Home
Office, complied with the Animals (Scientific Procedures) Act
1986, were approved by the University of Edinburgh Ethical
Review Committee, and were performed under the authority of
the UK Home Office Project Licence number 60/4105.
Parasites and Ags
H. polygyrus bakeri and N. brasiliensis were maintained, and adult
H. polygyrus HES was prepared as previously described [19, 23].
Egg burdens of individual mice were assessed by weighing feces
before dissolving in 2 mL PBS; following addition of 2 mL satu-
rated sodium chloride solution, egg counts were performed using
a McMaster chamber and the average number of eggs/g feces
calculated per sample.
In vivo Ab depletion
A neutralizing anti-IL-6 Ab (Clone MP5–20F3) or rat IgG (purified
from sera) were generated in-house and 200 μg injected i.p. on
days 0, 2, 4, and 6 postinfection, with cells harvested on day 7.
A neutralizing anti-IL-17 Ab (Clone 50104, Cat No MAB421) or
an IgG2a control (Clone 54447, Cat No MAB006) were purchased
from R&D Systems and 50 μg was injected i.p. on days 0, 3, 6,
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and 9 postinfection (total 200 μg) [62–64], with cells harvested
on day 14.
Preparation and administration of IL-2/anti-IL-2
complexes
Recombinant murine IL-2 and anti-mouse IL-2 (clone JES6–1A12)
were purchased from eBioscience with isotype control (rat IgG2a).
Immediately following infection with H. polygyrus, mice were
injected i.p. with 200 μL PBS solution containing 2.5 μg IL-2
and 25 μg anti-IL-2, which had been prepared and incubated for
30 min at room temperature before delivery.
In vitro Ag-specific restimulation
A single cell suspension was made of MLN before plating cells
at 1 × 106/well in the presence of 2 μg/mL HES and media
alone for 72 h at 37◦C/5% CO2. Supernatants were then harvested
and analyzed for IL-4, IL-10, and IL-13 by commercially available
ELISA (BD Pharmingen).
Treg induction
In vivo and in vitro Treg-cell induction was performed as pre-
viously described, by adoptive transfer of Foxp3-GFPxDO11.10
T cells into BALB/c mice, and by in vitro stimulation of purified
CD4+ T cells under Treg-inducing conditions [19].
Flow cytometry
All flow cytometry was performed using Becton-Dickinson Canto
or LSR-II flow cytometers. For Treg-cell phenotyping, 106 MLN
cells were stained with a combination of FITC-conjugated Abs to
CD4 or CD25; A700 or PerCP-conjugated CD4 and Biotin anti-
CD103 followed by Streptavidin PerCP for 20 min at 4◦C. Fol-
lowing fixation and permeabilization using the Foxp3 staining kit
(eBioscience), cells underwent intracellular staining with a com-
bination of PE-conjugated Abs to Helios [39] and APC or Pacific
Blue-conjugated Abs to Foxp3.
For intracellular cytokine staining, MLNCs were first incubated
with 0.5 μg/mL PMA and 1 μg/mL ionomycin for 1 h before
the addition of 10 μg/mL Brefeldin A for a further 3 h. Stain-
ing was performed by resuspending cells in a combination of
FITC conjugated Abs to CD8 or CD3 and CD19; PerCP conju-
gated anti-CD4 for 20 min at 4◦C, washed again then fixed for
20 min with 200 μL Fix/Perm buffer (BD Pharmingen). Fixa-
tion buffer was removed with two washes with permeabiliza-
tion buffer (BD Pharmingen) and samples were split and sub-
sequently stained for intracellular cytokines using 1/200 anti-
IFN-γ-allophycocyanin, anti-IL-4-PE, anti-IL-10-allophycocyanin,
anti-IL-13-allophycocyanin, anti-IL-17-PE, or the relevant isotype
control for 20 min in Perm buffer. Combined cytokine and Foxp3
staining was performed by fixation of cells following surface stain-
ing with the Foxp3 staining kit (eBioscience), with all subsequent
steps carried out in Foxp3 permeabilization buffer.
Statistical analysis
Data were assessed for normality and equal variances and were
log transformed if required; all data passed these criteria and an
unpaired t test was used or, where more than three groups were
being tested, a parametric one-way ANOVA followed by Tukey’s
multiple comparison test was used.
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